DNLI

DENALI THERAPEUTICS INC

Healthcare | Mid Cap

-$0.74

EPS Forecast

$1.19

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.74

Revenue Forecast:

$1.19

EPS Surprise Forecast:

$0.012

Revenue Surprise Forecast:

-$1

Post-release price volatility - High

Post-release Overnight Move:

±7.1%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

60%

Probability of beating revenue consensus:

45%

Probability of beating both EPS & revs consensus:

33%

Probability of missing both EPS & revs consensus:

28%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-3

Beta (β)

Forward Looking Beta (β):

2.00

Earnings volatility

EPS standard deviation:

$0.15

Revenue standard deviation:

$12

As % of share price:

0.74% HIGH

As % of market cap:

0.39% LOW

Confidence intervals and percentiles

EPS 95th %ile:

-$0.55

Revenue 95th %ile:

$17

EPS 75th %ile:

-$0.69

Revenue 75th %ile:

$5

EPS 25th %ile:

-$0.78

Revenue 25th %ile:

-$2

EPS 5th %ile:

-$0.90

Revenue 5th %ile:

-$12

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

38% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

71% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$17

Bid-ask per Share:

$0.035